HAVCR2 and neoplasm: Subsequent studies have found that Tim-3 is predominantly expressed on tumor-infiltrating Tregs in both human and experimental tumor models (120–126), and Tim-3+ Tregs exhibit enhanced suppressive capacity in in vitro suppression assays compared to Tim-3- Tregs (122, 124).